SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001193125-20-268644
Filing Date
2020-10-13
Accepted
2020-10-13 17:29:52
Documents
1

Document Format Files

Seq Description Document Type Size
1 POS AM d807448dposam.htm POS AM 19616
  Complete submission text file 0001193125-20-268644.txt   20721
Mailing Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884
Business Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884 (650) 614-5220
Aimmune Therapeutics, Inc. (Filer) CIK: 0001631650 (see all company filings)

IRS No.: 452748244 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-213499 | Film No.: 201237476
SIC: 2834 Pharmaceutical Preparations